Navigation Links
Effective mentoring critical to HIV/AIDS research efforts
Date:2/26/2009

tigators and optimizing their productivity. Open mentoring is a strategy that provides mentoring to persons desiring mentoring and is contrasted with elite mentoring in which mentoring is provided to those investigators who have achieved early success.

"Deciding to reserve mentoring for the top strata of early-career researchers does not broaden the pool of investigators. By making mentoring open to any investigator doing HIV research, we find that we are providing career support to a more diverse group of individuals from a more diverse set of research disciplines," said the article's co-author, Ruth M. Greenblatt, MD, UCSF professor of clinical medicine and co-director of the CFAR mentoring program.

The authors note other goals of the mentoring program, including retaining early-career investigators and optimizing their productivity and assisting them with transitions as their careers progress.

"The National Institutes of Health is limiting grant resubmissions due to funding constraints. Our mentors assist in optimizing grant submissions and ensuring mentees have a strong career strategy with appropriate expectations. Moreover, mentoring can be extremely helpful in assisting early-career investigators with the complicated but essential balancing of personal time with career advancement," said Greenblatt.

Greenblatt observed that the NIH has placed particular emphasis on the challenges faced by clinician scientists and noted that the country risks losing an entire generation of these essential investigators.

"We hear similar concerns from clinician scientists. They mention lack of access to funding, lack of caring for them as individuals and lack of a collegial atmosphere. Our mentoring serves as an intervention to specifically address these problems," said Greenblatt.


'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Physical therapy is effective for management of low-back pain
2. Health and Wellness Programs in a Tight Economy: Why They Are Critical and How to Make Them Effective
3. New bioPoint(TM) ID Nursing Home Visitor Software Cost-Effectively Enhances Security and Peace-of-Mind
4. LENA Foundation Technology Measures Effectiveness of Autism Therapy
5. Steroids ineffective in young children with wheeze
6. EMSI Realigns Internal Divisions for More Effective Focus on Customers
7. What is the most effective therapy for low-dose aspirin induced peptic ulcer?
8. Study shows ultrasound and tPA effective for stroke
9. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
10. MU researcher demonstrates non-traditional therapy is effective as pain management
11. Absolutely PR's Maggie Holben Participates In CBSA BioBreakfast Expert Panel "How to Garner Media Attention & Effectively Use Public Relations Tactics"

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel company launche... San Clemente, Calif. (PRWEB) ...through medical apparel, today announced the launc...Medica 2009, a leading international trade fair fo.... Medelita inaugurates its men,s collection with t...
(Date:11/21/2009)... New Haven Dental Group merges their practi...rd, CT. , (PRWEB) Novembe...d of partners Dr. David Gibson, Dr. Dean Cloutier,...ust merged their growing practice with that of est.... Pickman decided he wanted to retire from dentist...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)..., Nov. 20 The American ... and Drug Administration (FDA) to establish approp...s. ,, Citing concern about the safety of white...the benefit of professional consultation or examin...application of chemically based tooth whitening or...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...sLuce Vice President Johna Burke will describe com...gap in remarks to be delivered on Tuesday, Jan. 6,...by the South Carolina Chapter of the International...ello at 803-255-2635 or stefanie.caraviello (at) s...
...chnology, Inc. (eRT), (Nasdaq: ERES ), a leading...ogy, ePRO and other services to the pharmaceutical...ries, announced today that Dr. Michael J. McKelvey...Annual J.P. Morgan Healthcare Conference at 4:00 p...
...x, Inc. (Nasdaq: MSON ), a developer of minimall...hich in Europe is used for the ablation of tumors ...as entered into a definitive, 3-year distribution ...nnounced on November 7, 2008. Under the terms of t...
...8Scientists at Burnham Institute for Medical Resea...s for the protein kinase complex Cdc7/Dbf4 or Cdc7...A replication and reinitiating replication followi...herapies. The research was published in the Decemb...
...adon Action Month, , , HARRISBURG, Pa., Jan. 5 U...s seeping into homes could help prevent lung cance...f Environmental Protection Secretary John Hanger s...re stores or by contacting a Pennsylvania certifie...
...in have been used for centuries to treat patients ... are still in use today. In the Dec. 16 issue of t...s , researchers at the Johns Hopkins University Sc...isting drugs that might slow or stop cancer progre...
Other Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3Health News:eResearchTechnology, Inc. to Present at the J.P. Morgan Healthcare Conference on January 13, 2009 2Health News:Misonix Announces New HIFU Distribution Agreement for Italy 2Health News:Misonix Announces New HIFU Distribution Agreement for Italy 3Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2Health News:Inexpensive Test Can Help Prevent Lung Cancer Caused By Radon 2Health News:New hope for cancer comes straight from the heart 2
(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...
(Date:11/19/2009)...ewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc....te presentation will be webcast live during the 21...Wednesday, December 2, 2009 at 9:00 a.m. Eastern T...w York Palace Hotel in New York and will be presen... ,, To access the live presentation via the Web...
(Date:11/19/2009)...wire/ -- Ligon Discovery, Inc., which uses proprie...drugs against high-value targets, today announced ...cTANK Ventures. The company will use the capital t...l screen over 100 high-value disease protein targe... Partner Christian Bailey joins the board. ,, P...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 1Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 2Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 4Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 5Hip Arthroscopy Procedures to Soar Through 2013 51045 1Hip Arthroscopy Procedures to Soar Through 2013 51045 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 1DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 3DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 4DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 5
... Phase 1/2 Trial of TRU-016, Trubion,s Proprietary...I-087 for RA Expands Trubion,s Family of Customize...t Candidates, SEATTLE, March 27 Trubion Pharmace... it has initiated a Phase 1/2,clinical trial of TR...r,ImmunoPharmaceutical (SMIP(TM)) drug candidate, ...
...ng Therapeutic Value of Cord Blood Stem Cells, OL...bilical cord blood are showing early potential in ... from a new preclinical study,published in the Mar...conducted by researchers from the University of So...ound that targeted immune suppression using stem,c...
Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 2Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 3Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 4Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 5
New Image Pre-sized Flextend Skin Barrier, Floating Flange, with Tape
New Image Pre-sized Flextend Skin Barrier, Floating Flange
New Image Pre-sized Convex FlexWear Skin Barrier, Floating Flange
New Image Pre-Sized Convex Flextend Skin Barrier, Floating Flange
Medicine Products: